AJ Pharma H9olding
AJ Pharma Holding, headquartered in Malaysia, is a prominent player in the pharmaceutical and biotechnology industry. Founded in 2015, the company has rapidly established itself as a leader in the development and manufacturing of innovative healthcare solutions across the Asia-Pacific region. Specialising in biopharmaceuticals, AJ Pharma Holding focuses on producing high-quality biosimilars and advanced therapeutics, setting itself apart with a commitment to rigorous quality standards and cutting-edge technology. The company has achieved significant milestones, including successful product launches and strategic partnerships that enhance its market position. With a strong emphasis on research and development, AJ Pharma Holding continues to expand its portfolio, aiming to address unmet medical needs and improve patient outcomes. Its dedication to excellence has garnered recognition within the industry, solidifying its reputation as a trusted name in healthcare innovation.
DitchCarbon Score
How does AJ Pharma H9olding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AJ Pharma H9olding's score of 20 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AJ Pharma H9olding's reported carbon emissions
AJ Pharma Holding, headquartered in Malaysia, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. In the absence of concrete emissions data, it is important to note that AJ Pharma Holding has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, AJ Pharma Holding's future initiatives may align with broader industry trends aimed at reducing carbon emissions and enhancing environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AJ Pharma H9olding is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
